These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 18175395)

  • 21. Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.
    Bognar C; Baldovic M; Benetin J; Kadasi L; Zatkova A
    Gen Physiol Biophys; 2013 Mar; 32(1):55-66. PubMed ID: 23531835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
    Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
    Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic basis of Parkinson disease.
    Xiromerisiou G; Dardiotis E; Tsimourtou V; Kountra PM; Paterakis KN; Kapsalaki EZ; Fountas KN; Hadjigeorgiou GM
    Neurosurg Focus; 2010 Jan; 28(1):E7. PubMed ID: 20043722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
    Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
    Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
    Cookson MR; Xiromerisiou G; Singleton A
    Curr Opin Neurol; 2005 Dec; 18(6):706-11. PubMed ID: 16280683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
    Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
    Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics of Parkinson disease.
    Domingo A; Klein C
    Handb Clin Neurol; 2018; 147():211-227. PubMed ID: 29325612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The curious case of phenocopies in families with genetic Parkinson's disease.
    Klein C; Chuang R; Marras C; Lang AE
    Mov Disord; 2011 Aug; 26(10):1793-802. PubMed ID: 21735483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease: insights from pathways.
    Cookson MR; Bandmann O
    Hum Mol Genet; 2010 Apr; 19(R1):R21-7. PubMed ID: 20421364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autosomal dominant Parkinson's disease and the route to new therapies.
    Morris HR
    Expert Rev Neurother; 2007 Jun; 7(6):649-56. PubMed ID: 17563248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
    Wider C; Foroud T; Wszolek ZK
    Mov Disord; 2010; 25 Suppl 1():S15-20. PubMed ID: 20187245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease.
    Quattrone A; Bagnato A; Annesi G; Novellino F; Morgante L; Savettieri G; Zappia M; Tarantino P; Candiano IC; Annesi F; Civitelli D; Rocca FE; D'Amelio M; Nicoletti G; Morelli M; Petrone A; Loizzo P; Condino F
    Mov Disord; 2008 Jan; 23(1):21-7. PubMed ID: 17975812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of Parkinson's disease.
    Yang YX; Wood NW; Latchman DS
    Neuroreport; 2009 Jan; 20(2):150-6. PubMed ID: 19151598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
    Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of Parkinson's disease.
    Morris HR
    Ann Med; 2005; 37(2):86-96. PubMed ID: 16026116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative contribution of simple mutations vs. copy number variations in five Parkinson disease genes in the Belgian population.
    Nuytemans K; Meeus B; Crosiers D; Brouwers N; Goossens D; Engelborghs S; Pals P; Pickut B; Van den Broeck M; Corsmit E; Cras P; De Deyn PP; Del-Favero J; Van Broeckhoven C; Theuns J
    Hum Mutat; 2009 Jul; 30(7):1054-61. PubMed ID: 19405094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular genetics of PINK1].
    Funayama M; Hattori N
    Brain Nerve; 2007 Aug; 59(8):831-8. PubMed ID: 17713119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.